Gentamicin implant - Innocoll

Drug Profile

Gentamicin implant - Innocoll

Alternative Names: Cogenzia; CollaRx; CollaRx® gentamicin topical - Innocoll; Collatamp EG; Collatamp G; Collatamp G topical; Cronocol; Duracoll; Garacol; Garacoll; Garamycin Schwamm; Gentacol; Gentacoll; Gentalyn; Gentamicin surgical implant - Innocoll; Gentamicin-collagen Topical; Gentimplant; INL-002; Sulmycin Implant; Sulmycin Implant E; Sulmycin Schwamm

Latest Information Update: 17 Jul 2018

Price : $50 *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Essex Chemie; Innocoll
  • Developer Innocoll; Premier Research Group
  • Class Aminoglycosides; Anti-infectives; Antibacterials; Small molecules
  • Mechanism of Action Protein 30S ribosomal subunit inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Marketed Postoperative infections
  • Phase III Diabetic foot ulcer

Most Recent Events

  • 11 Jul 2018 EUSA Pharma enters into an agreement to sell its critical care business including Collatamp® SERB Pharmaceuticals
  • 24 Jul 2017 Innocoll has been acquired by Gurnet point capital
  • 03 Nov 2016 Topline efficacy and adverse events data from the phase III COACT-1 and COACT-2 studies in Diabetic foot ulcer (Combination therapy, In adults, In the elderly) released by Innocoll
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top